Everolimus-eluting stent versus bare-metal stent in elderly (>= 75 years) versus non-elderly (<75 years) patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Insights from the examination trial

摘要

Background: The elderly (>= 75 years) constitute a high-risk subset of patients who continue to have a poorer prognosis than non-elderly (<75 years). Whether the effects of everolimus-eluting stent (EES) in ST-segment elevation myocardial infarction (STEMI) are independent of age has not been reported. We investigated the outcomes following primary PCI (PPCI) with bare-metal stent (BMS) or EES in elderly vs. non-elderly STEMI patients.